Anti-TNF Therapies Carry Varying Levels of TB Risk (CME/CE)

Courtesy MedPage Today Infectious Disease  Thu, 07/02/2009 - 07:59

LITTLE FALLS, N.J. (MedPage Today) -- The risk of tuberculosis is higher for patients receiving anti-tumor necrosis factor (anti-TNF) monoclonal antibody therapy than for those receiving soluble TNF receptor therapy for any indication, French researchers found.


 

More related items

Anti-TNF Antibodies May Boost Herpes Zoster Risk
BERLIN (MedPage Today) -- Herpes zoster infection could arise from treatment of rheumatoid arthritis with a monoclonal antibody against tumor necrosis factor, investigators here concluded.

FDA Unveils New Safety Plan for Medical Imaging
WASHINGTON (MedPage Today) -- The Food and Drug Administration (FDA) announced it plans to issue new safety requirements for manufacturers of CT and fluoroscopic devices to reduce unnecessary...

FDA Revises HIV Drug Label for Liver Complication
WASHINGTON (MedPage Today) -- The FDA has updated labels of the HIV drug didanosine (Videx and Videx EC) to include warnings for potentially serious liver damage.

Pedifix Wart Stick Solid-stick Wart Remover Net...
No more embarrassment! Wart STICK 's exclusive formula contains 40% salicylic acid, the #1 doctor-recommended ingredient for wart removal. This unique product delivers the medicine through an...

Ride 'Em Cowgirl! Sex Position Secrets For Better...
Why is this today s best sex position guide? Instead of twisting you into impossible pretzel poses, Dr. Sadie illustrates hundreds of ways to shape your favorite sex positions into a more...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com